Who is the CEO of Artemis Therapeutics Inc.?

The CEO of Artemis Therapeutics Inc. is Shimon Citron.

What industry does Artemis Therapeutics Inc. belong to?

Artemis Therapeutics Inc. operates in the Shell Companies industry within the Financial Services sector.

Where is Artemis Therapeutics Inc. headquartered?

Artemis Therapeutics Inc. is headquartered at 18 East 16th Street, New York City, NY, 10003, US.

What is the IPO date of Artemis Therapeutics Inc.?

Artemis Therapeutics Inc. went public on February 17, 1998.

How many employees does Artemis Therapeutics Inc. have?

Artemis Therapeutics Inc. has approximately 4 full-time employees.

Artemis Therapeutics Inc.

ATMS•PNK

Financial Services

Shell Companies

$0.50

$-1.39(-73.65%)

Artemis Therapeutics Inc. (ATMS) Company Profile & Overview

Explore Artemis Therapeutics Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Artemis Therapeutics Inc. (ATMS) Company Profile & Overview

Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.

SectorFinancial Services

IndustryShell Companies

CEOShimon Citron

Contact Information

https://www.artemis-therapeutics.com

646 233 1454

18 East 16th Street, New York City, NY, 10003

Company Facts

4 Employees

IPO DateFeb 17, 1998

CountryUS

Frequently Asked Questions

;